143 related articles for article (PubMed ID: 14752169)
1. Osteoarthritis--the impact of a serious disease.
Breedveld FC
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i4-8. PubMed ID: 14752169
[TBL] [Abstract][Full Text] [Related]
2. Osteoarthritis therapy--are there still unmet needs?
Laufer S
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i9-15. PubMed ID: 14752170
[TBL] [Abstract][Full Text] [Related]
3. Impact of disease severity and gastrointestinal side effects on the health state preferences of patients with osteoarthritis.
Chang J; Kauf TL; Mahajan S; Jordan JM; Kraus VB; Vail TP; Reed SD; Omar MA; Kahler KH; Schulman KA
Arthritis Rheum; 2005 Aug; 52(8):2366-75. PubMed ID: 16052538
[TBL] [Abstract][Full Text] [Related]
4. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
[TBL] [Abstract][Full Text] [Related]
5. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
6. Safety of anti-inflammatory treatment--new ways of thinking.
Brune K
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i16-20. PubMed ID: 14752171
[TBL] [Abstract][Full Text] [Related]
7. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
[TBL] [Abstract][Full Text] [Related]
8. Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.
Alvaro-Gracia JM
Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i21-5. PubMed ID: 14752172
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis.
Wallace JL; Viappiani S; Bolla M
Trends Pharmacol Sci; 2009 Mar; 30(3):112-7. PubMed ID: 19230986
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.
Pareek A; Chandanwale AS; Oak J; Jain UK; Kapoor S
Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320
[TBL] [Abstract][Full Text] [Related]
11. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis.
Yilmaz H; Gürel S; Ozdemir O
Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for osteoarthritis.
Singh G
Surg Technol Int; 2003; 11():287-92. PubMed ID: 12931313
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations.
Lazzaroni M; Bianchi Porro G
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():48-58. PubMed ID: 15335413
[TBL] [Abstract][Full Text] [Related]
14. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs.
Pilotto A; Franceschi M; Vitale DF; Zaninelli A; Masotti G; Rengo F; ;
Aliment Pharmacol Ther; 2005 Jul; 22(2):147-55. PubMed ID: 16011673
[TBL] [Abstract][Full Text] [Related]
15. Treating the symptoms of osteoarthritis-oral treatments.
McMahon K; Nelson M; Jones G
Aust Fam Physician; 2008 Mar; 37(3):133-5. PubMed ID: 18345361
[TBL] [Abstract][Full Text] [Related]
16. Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs.
Briesacher B; Kamal-Bahl S; Hochberg M; Orwig D; Kahler KH
Arch Intern Med; 2004 Aug 9-23; 164(15):1679-84. PubMed ID: 15302639
[TBL] [Abstract][Full Text] [Related]
17. The impact of osteoarthritis in the United States: a population-health perspective.
Murphy L; Helmick CG
Am J Nurs; 2012 Mar; 112(3 Suppl 1):S13-9. PubMed ID: 22373741
[TBL] [Abstract][Full Text] [Related]
18. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
[TBL] [Abstract][Full Text] [Related]
19. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
20. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
Joshua FF; Oakley SP; Major GA
Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
